相关实验视频

Updated: Jun 13, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

精神迷幻药在治疗耐药抑郁症 (TRD) 的有效性,安全性和耐受性

Berend Olivier^1,2, Jocelien D A Olivier³

¹Department of Psychopharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. b.olivier@uu.nl.

Advances in experimental medicine and biology

|September 11, 2024

概括

新的迷幻药物,包括 псилоцибин和埃斯基坦胺,显示出治疗耐治疗抑郁症 (TRD) 的前景. 这些新疗法提供了快速和持续的抗抑郁作用,代表了精神病治疗的突破.

科学领域:

精神病学是一个精神病学.
神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

大型抑郁症 (MDD) 影响了许多人,大约30%的人经历了耐治疗抑郁症 (TRD),对传统疗法没有反应.
TRD缺乏通用定义,但通常被理解为对两种或更多抗抑郁药物治疗缺乏反应.
最近的研究重点是用于TRD的新型迷幻化合物.

研究的目的:

描述用于TRD的psilocybin和esketamine的临床发展.
讨论因其精神活性作用而导致的迷幻药的安慰剂对照试验中的挑战.
评估这些新型药物的疗效和安全性.

主要方法:

在TRD中审查psilocybin和esketamine的临床发展途径.
对心理模拟药物和离散药物的盲目的研究设计的挑战分析.
评估报告的不良反应和耐受性.

主要成果:

鼻腔内胺被批准用于TRD,而psilocybin已经证明了积极的临床结果.
псилоцибин和埃斯基他明都表现出迅速发作和长期持续的抗抑郁药物效应.
副作用和耐受性在治疗剂量范围内通常是可以接受的.

结论:

西和胺代表了治疗严重抑郁症的重大进展.
这些新的基于迷幻的治疗方法为TRD患者提供了新的希望.
这些新兴疗法需要进一步的研究和临床应用.

关键词:

它是5-HT2A受体的激动剂.抗抑郁药是一种抗抑郁药.阿雅华斯卡 (Ayahuasca) 是一种葡萄酒.抑郁症抑郁症抑郁症分离分离分离分离.有效性有效性.异构体异构体异构体异构体异构体异构体艾斯凯特胺是什么意思胺基氨酸 (ketamine) 是一种可以它是NMDA受体对抗剂.这种药物是psilocybin.迷幻药物迷幻药物这是心理模拟的.安全的安全的安全的安全的安全.耐受性耐受性治疗耐药性抑郁症的治疗方法

更多相关视频

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

CNS Stimulants: Psychedelic Agents

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...

Hallucinogens and Psychedelics

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...